Some Counterclaims Tossed In Roche Suit Over Xeloda
A federal judge has dismissed claims, counterclaims and defenses arising from five unasserted claims in Hoffmann-La Roche Inc.'s lawsuit against Mylan Pharmaceuticals Inc. over a patent for the oral chemotherapy drug...To view the full article, register now.
Already a subscriber? Click here to view full article